Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i de » i e (Expand Search), i d (Expand Search), _ de (Expand Search)
Showing 2,001 - 2,020 results of 105,902 for search '(( i de decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 2001
    Antibody-dependent cellular cytotoxicity (ADCC) of HIV-1-infected target cells is boosted by RV305 vaccination.

    Antibody-dependent cellular cytotoxicity (ADCC) of HIV-1-infected target cells is boosted by RV305 vaccination. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  2. 2002
    Longitudinal YU2 gp120 WT-reactive CD4i IgG binding antibodies elicited in RV144 and RV305 (related to Fig 1).

    Longitudinal YU2 gp120 WT-reactive CD4i IgG binding antibodies elicited in RV144 and RV305 (related to Fig 1). by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  3. 2003
    Primary and exploratory statistical analysis: comparison of binding antibody multiplex assay (BAMA) total IgG and IgG1 response magnitudes at RV144 week 26 versus RV305 week 2, RV305 week 2 versus RV305 week 26, and RV144 week 26 versus RV305 week 26.

    Primary and exploratory statistical analysis: comparison of binding antibody multiplex assay (BAMA) total IgG and IgG1 response magnitudes at RV144 week 26 versus RV305 week 2, RV3... by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  4. 2004
    Durability of IgG3 responses.

    Durability of IgG3 responses. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  5. 2005
    Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG3 response magnitudes between the Combination (ALVAC-HIV + AIDSVAX B/E) group (group 1) and AIDSVAX B/E only group (group 2) at RV305 week 2 and RV305 week 26.

    Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG3 response magnitudes between the Combination (ALVAC-HIV + AIDSVAX B/E) group (group 1) and A... by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  6. 2006
    Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG4 response magnitudes between the Combination (ALVAC-HIV + AIDSVAX B/E) group (group 1) and AIDSVAX B/E only group (group 2) at RV305 week 2 and RV305 week 26.

    Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG4 response magnitudes between the Combination (ALVAC-HIV + AIDSVAX B/E) group (group 1) and A... by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  7. 2007
    Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) total IgG and IgG1 response magnitudes between the Combination (ALVAC-HIV + AIDSVAX B/E) group (group 1) and AIDSVAX B/E only group (group 2) at RV305 week 2 and RV305 week 26.

    Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) total IgG and IgG1 response magnitudes between the Combination (ALVAC-HIV + AIDSVAX B/E) group (... by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  8. 2008
    Primary and exploratory statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG3 breadth scores at RV144 week 26 versus RV305 week 2 (primary analysis), RV305 week 2 versus RV305 week 26, and RV144 week 26 versus RV305 week 26 (exploratory analysis).

    Primary and exploratory statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG3 breadth scores at RV144 week 26 versus RV305 week 2 (primary analysis), RV3... by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  9. 2009
    Linear epitope mapping of RV305 plasma.

    Linear epitope mapping of RV305 plasma. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  10. 2010
    Lack of RSC3-reactive CD4 binding site IgG antibodies elicited in RV144 and RV305.

    Lack of RSC3-reactive CD4 binding site IgG antibodies elicited in RV144 and RV305. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  11. 2011
    Durability of Env gp120 IgG responses.

    Durability of Env gp120 IgG responses. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  12. 2012
    Delayed boost lowers IgG3.

    Delayed boost lowers IgG3. by LaTonya D. Williams (3140490)

    Published 2023
    “…<p><b>(A)</b> Response rate (top panel) and response magnitude (bottom panel) for HIV-1 envelope-specific IgG3 in plasma at two weeks post final RV144 vaccination (week 26) and two weeks post first and second RV305 boosts (weeks 2 and 26, respectively) against four vaccine-matched antigens (A244 D11 gp120, MN gp120, 92TH023 gp120, and AE.A244 V1V2 tags) identified as primary immune variables. …”
    Save to List
    Saved in:
  13. 2013
    Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on early cytokine response after cecal ligation and puncture (CLP)-induced sepsis.

    Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on early cytokine response after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

    Published 2015
    Save to List
    Saved in:
  14. 2014
    Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases IgG and IgG1 breadth.

    Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases IgG and IgG1 breadth. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  15. 2015
    Table_1_SARS-CoV-2 Variant Determination Through SNP Assays in Samples From Industry Workers From Rio de Janeiro, Brazil.DOCX

    Table_1_SARS-CoV-2 Variant Determination Through SNP Assays in Samples From Industry Workers From Rio de Janeiro, Brazil.DOCX by Bianca Monteiro Henriques-Santos (12061607)

    Published 2022
    “…<p>Since the first reported case in December 2019, SARS-CoV-2 infections have become a major public health worldwide. …”
    Save to List
    Saved in:
  16. 2016
    Trypanosome locomotion with a decreased body stiffness of , which leads to an increase in both the swimming velocity and rotation frequency when compared to the reference case in S1V.

    Trypanosome locomotion with a decreased body stiffness of , which leads to an increase in both the swimming velocity and rotation frequency when compared to the reference case in S1V. by Florian A. Overberg (21402904)

    Published 2025
    “…<p>Trypanosome locomotion with a decreased body stiffness of , which leads to an increase in both the swimming velocity and rotation frequency when compared to the reference case in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013111#pcbi.1013111.s003" target="_blank">S1V</a>.…”
    Save to List
    Saved in:
  17. 2017
    The prediction result is displayed on the hotel dataset, which includes the training procedure when the loss function is decreased and the model saved with training rounds as a multiple of five.

    The prediction result is displayed on the hotel dataset, which includes the training procedure when the loss function is decreased and the model saved with training rounds as a multiple of five. by Hongxia Wang (241142)

    Published 2025
    “…<p>The prediction result is displayed on the hotel dataset, which includes the training procedure when the loss function is decreased and the model saved with training rounds as a multiple of five.…”
    Save to List
    Saved in:
  18. 2018
    Data_Sheet_5_Chronic Neurobehavioral Impairments and Decreased Hippocampal Expression of Genes Important for Brain Glucose Utilization in a Mouse Model of Mild TBI.xlsx

    Data_Sheet_5_Chronic Neurobehavioral Impairments and Decreased Hippocampal Expression of Genes Important for Brain Glucose Utilization in a Mouse Model of Mild TBI.xlsx by Linda M. Huynh (9395591)

    Published 2020
    Save to List
    Saved in:
  19. 2019
    Image5_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF

    Image5_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…External validation based on multidimensional online databases and scRNA-seq analysis were used to verify our key findings.</p><p>Results: A six-different-dimension regulatory network was constructed based on 17 DEeRNAs, 29 DETFs, 9 DETGs, 5 immune cells, 24 immune gene sets, and 8 hallmarks of cancer. …”
    Save to List
    Saved in:
  20. 2020
    Decreased serum IgG2a, IgG2b and IgG3 levels in IRF5-deficient MRL/lpr mice.

    Decreased serum IgG2a, IgG2b and IgG3 levels in IRF5-deficient MRL/lpr mice. by Kei Yasuda (606333)

    Published 2014
    Save to List
    Saved in:

Search Tools: